Article
Response to cholesterol-lowering drugs in familial defective apolipoprotein B-100.
Atherosclerosis - 1 Nov 1991
Maher V M, Gallagher J J, Thompson G R, Myant N B
Abstract excerpt
The effect of cholestyramine and simvastatin, given separately or in combination, on serum lipid concentrations in 11 patients with heterozygous familial defective apolipoprotein B-100 was compared with that in 11 matched patients with heterozygous familial hypercholesterolaemia. In both groups of patients there was a substantial fall in serum lipid levels in response to treatment. There were no significant...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.